Madison Asset Management LLC Makes New Investment in ICU Medical, Inc. $ICUI

Madison Asset Management LLC acquired a new stake in ICU Medical, Inc. (NASDAQ:ICUI) in the first quarter, Holdings Channel.com reports. The institutional investor acquired 18,061 shares of the medical instruments supplier’s stock, valued at approximately $2,333,000.

A number of other institutional investors have also recently bought and sold shares of the business. Millennium Management LLC increased its position in shares of ICU Medical by 173.4% during the 3rd quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier’s stock valued at $130,638,000 after purchasing an additional 690,694 shares during the last quarter. Norges Bank bought a new position in ICU Medical during the fourth quarter valued at about $58,083,000. Thrivent Financial for Lutherans grew its position in ICU Medical by 1,604.0% during the fourth quarter. Thrivent Financial for Lutherans now owns 303,457 shares of the medical instruments supplier’s stock valued at $43,294,000 after buying an additional 285,648 shares during the period. UBS Group AG increased its holdings in ICU Medical by 239.8% during the third quarter. UBS Group AG now owns 386,555 shares of the medical instruments supplier’s stock worth $46,371,000 after buying an additional 272,782 shares during the last quarter. Finally, Brown Advisory Inc. purchased a new stake in ICU Medical during the fourth quarter worth about $32,445,000. Institutional investors own 96.10% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on ICUI. BTIG Research started coverage on shares of ICU Medical in a research report on Monday, June 15th. They issued a “buy” rating and a $170.00 price objective on the stock. Weiss Ratings raised shares of ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, May 11th. Sanford C. Bernstein lowered shares of ICU Medical to a “market perform” rating in a research note on Monday, June 15th. Needham & Company LLC raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $165.00 price target on the stock in a report on Wednesday, May 27th. Finally, Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a research note on Thursday, May 7th. Three equities research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, ICU Medical has an average rating of “Buy” and a consensus price target of $172.00.

Insider Activity at ICU Medical

In related news, VP Virginia Ruth Sanzone sold 2,447 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $124.08, for a total transaction of $303,623.76. Following the sale, the vice president directly owned 19,460 shares in the company, valued at approximately $2,414,596.80. This represents a 11.17% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director David C. Greenberg sold 2,424 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $122.91, for a total transaction of $297,933.84. Following the sale, the director owned 7,960 shares in the company, valued at $978,363.60. The trade was a 23.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 2.10% of the company’s stock.

ICU Medical Trading Up 0.9%

Shares of ICUI opened at $158.77 on Wednesday. ICU Medical, Inc. has a fifty-two week low of $107.00 and a fifty-two week high of $162.85. The business has a 50-day moving average of $142.12 and a 200 day moving average of $139.41. The firm has a market cap of $3.97 billion, a P/E ratio of 85.82, a price-to-earnings-growth ratio of 2.20 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.17 and a current ratio of 2.34.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, beating the consensus estimate of $1.78 by $0.19. The business had revenue of $525.77 million for the quarter, compared to the consensus estimate of $520.65 million. ICU Medical had a net margin of 2.15% and a return on equity of 7.50%. The company’s revenue was down 12.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.72 earnings per share. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. As a group, research analysts forecast that ICU Medical, Inc. will post 6.51 EPS for the current year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.